Synthetic high-density lipoprotein-like nanoparticles for cancer therapy
- PMID: 25487833
- PMCID: PMC4638421
- DOI: 10.1586/14737140.2015.990889
Synthetic high-density lipoprotein-like nanoparticles for cancer therapy
Abstract
High-density lipoproteins (HDLs) are a diverse group of natural nanoparticles that are most well known for their role in cholesterol transport. However, HDLs have diverse functions that provide significant opportunities for cancer therapy. Presented is a focused review of the ways that synthetic versions of HDL have been used as targeted therapies for cancer, and as vehicles for the delivery of diverse therapeutic cargo to cancer cells. As such, synthetic HDLs are likely to play a central role in the development of next-generation cancer therapies.
Keywords: cancer; cholesterol; drug delivery; high-density lipoprotein; nucleic acids; scavenger receptor.
References
-
-
Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Frontiers in pharmacology. 2013;4:119. **An informative review detailing the role of cholesterol in cancer.
-
-
- Brown AJ. Cholesterol, statins and cancer. Clin Exp Pharmacol P. 2007;34(3):135–141. - PubMed
-
- Simons K, Ikonen E. How cells handle cholesterol. Science. 2000;290(5497):1721–1726. - PubMed
-
- Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Bio. 2010;11(10):688–699. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials